| Date |
Announcements
|
Attachment |
| Sep 2, 2010 |
Avexa Engages BioAdvisory Group |
 PDF file - 53.68 KB
|
| Aug 26, 2010 |
Preliminary Final Report 2010 |
PDF file - 653.61 KB
|
| Aug 26, 2010 |
Audited Accounts 2010 |
PDF file - 1.67 MB
|
| Aug 26, 2010 |
Proxy Form AUG 2010 |
PDF file - 261.53 KB
|
| Aug 26, 2010 |
Notice Of Meeting AUG |
PDF file - 229.38 KB
|
| Aug 10, 2010 |
Avexa receives request from Calzada for General Meeting |
PDF file - 49.5 KB
|
| Aug 9, 2010 |
Avexa appoints new Non-Executive Director |
PDF file - 53.08 KB
|
| Jul 23, 2010 |
Quarterly News Report to Shareholders for July 2010. |
PDF file - 1.08 MB
|
| Jul 14, 2010 |
Avexa licenses one of its HIV integrase programs to Chinese partner |
PDF file - 57.21 KB
|
| Jul 13, 2010 |
Avexa announces new appointments |
PDF file - 56.69 KB
|
| Jul 8, 2010 |
Avexa Announces Resignation of Director Mr David Bottomley |
PDF file - 49.7 KB
|
| Jul 7, 2010 |
Avexa appoints new Chairman and Board members |
PDF file - 55.62 KB
|
| Jun 25, 2010 |
Board Letter to Shareholders |
PDF file - 37.15 KB
|
| May 31, 2010 |
Correction of typographical error in Notice of Meeting |
PDF file - 28.15 KB
|
| May 26, 2010 |
General Meeting Proxy Form |
PDF file - 240.25 KB
|
| May 26, 2010 |
Notice of General Meeting |
PDF file - 155.68 KB
|
| May 20, 2010 |
Avexa appoints Uri Ratner to Board of Directors |
PDF file - 34.18 KB
|
| May 20, 2010 |
Avexa announces resignation of Director Mr Joe Baini |
PDF file - 28.7 KB
|
| May 11, 2010 |
Letter to shareholders |
PDF file - 62.18 KB
|
| May 10, 2010 |
Avexa receives request for general meeting |
PDF file - 29.13 KB
|
| May 10, 2010 |
Avexa closes apricitabine program |
PDF file - 45.82 KB
|
| Apr 22, 2010 |
March 2010 Quarterly Cash Flow Statement |
PDF file - 45.69 KB
|
| Mar 23, 2010 |
Avexa announces detailed ATC Phase III results at 24 weeks |
PDF file - 68.68 KB
|
| Mar 19, 2010 |
Avexa exits CSIRO's AGPP arrangement |
PDF file - 56.92 KB
|
| Mar 1, 2010 |
Expiry of HIV Integrase Option Period with Tibotec |
PDF file - 57.46 KB
|
| Feb 15, 2010 |
Avexa reports positive phase IIb 144 week data for HIV drug apricitabine |
PDF file - 66.42 KB
|
| Feb 4, 2010 |
Avexa announces ATC phase III top line results |
PDF file - 68.87 KB
|
Our attachments use Adobe PDF which means you may have to use an Acrobat Reader. You can
